The end of summer doesn�t mean the end of mosquito season.  So the West Nile Virus will remain a threat well into the fall.  With over 23-hundred cases this year and 44 deaths, finding a cure is critical.  There�s no treatment for West Nile Virus yet, but a company called A-V-I BioPharma is working to change that.  Last fall A-V-I BioPharma successfully treated penguins infected with the virus at a Wisconsin zoo.  The company just became the first to begin clinical testing of a drug for West Nile patients in hospitals around the U.S.  Alan Timmins of A-V-I BioPharma: 

�We�ve gone from understanding the West Nile Virus genetic code to starting the trial in just nine months, which is a huge accomplishment. We�re confident that this drug has the potential to make a difference in the fight against West Nile Virus.� 

To learn more about A-V-I BioPharma and its West Nile trials, go to avibio.com.